US$ 20.19
glp 1 agonist cardioprotective Glucagon-like peptide receptor agonists: cardiovascular benefits and mechanisms of action Diabetic Agents, From Metformin to
Description
CU Cancer Center member Bryan Haugen, MD, breaks down the science behind the FDA warning on the GLP-1 weight-loss medications.

GLP-1 drugs like Ozempic and Mounjaro may offer real benefits for people with type 1 diabetes: less insulin, flatter CGM curves, and emerging evidence for heart and kidney protection.

While weight loss effects can vary depending on the drug, studies show that all GLP-1 meds can result in an average weight loss of about 10.5 to 15.8 []
has details on the plan to remove auto-injectors in order to allow greater access to patients at lower prices.

Curious about GLP-1 medications like Ozempic and Wegovy

Over 30 years ago scientists discovered the potential of Gila monster venom as a treatment for type 2 diabetes.